SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs.
“For far too long, pharmacy benefit managers (PBMs) have taken advantage of the lack of transparency in our healthcare system, establishing monopolistic control over the delivery of pharmacy services and significantly increasing what Americans pay for prescription medications. Anticompetitive PBMs practices have created a healthcare crisis, threatening the survival of pharmacies, including those that provide essential services to millions of patients in long-term care.”
“We commend President Trump’s efforts to address harmful PBM behavior by restoring competition, ensuring fair contracting and promoting transparency in our healthcare system. We encourage leaders in Congress—especially those who have already been championing PBM reform—to heed the President’s call for action and deliver meaningful reform that protects LTC pharmacies and the millions of seniors they serve.”
“LTC pharmacies are uniquely impacted by both aggressive PBM actions and recent Medicare Part D drug pricing policy changes included in the Inflation Reduction Act (IRA) that threaten the viability of many essential pharmacies across the country. The current Medicare pharmacy payment model is broken and forces LTC pharmacies to dispense medicines at a loss while PBMs and Part D plans reap massive profits. This problem will only worsen when new Medicare negotiated drug prices take effect in January 2026.”
“While there are many details for Congress to consider, Members must quickly follow through on President Trump’s Executive Order to protect seniors’ access to medicines and essential pharmacy services. We look forward to working with the White House, HHS and Congressional leaders to establish meaningful policy solutions that ensure the continued delivery of quality long-term care, support continued pharmaceutical innovation and protect the needs of America’s most vulnerable patients.”
Statement should be attributed to Alan Rosenbloom, President and CEO of SCPC.
###
Recent Posts
-
SCPC Urges Congress to Include LTC Pharmacy Fix in Reconciliation Package to Save Prescription Drug Access for Seniors in Long-Term Care
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement regarding the reconciliation package passed by the House Energy and Commerce Committee on May 14.
-
SCPC Applauds Senate Judiciary Committee for Spotlighting PBM Anticompetitive Behavior, Urges Immediate Action on PBM Reform
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement thanking Senate Judiciary Chairman Chuck Grassley and members of the Committee for prioritizing pharmacy benefit manager (PBM) reform during today’s hearing, “PBM Power Play: Examining Competition Issues in the Prescription Drug Supply Chain.”
-
Policies Aimed at Lowering Drug Prices Must Ensure Patients See Lower Costs While Preserving Access to Essential LTC Pharmacy Services
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement regarding President Trump’s May 12 Executive Order on prescription drug prices, urging the White House to also address the critical LTC Pharmacy Fix and protect seniors’ access to medications.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.